Trial Profile
Phase III trial of oral parathyroid hormone in women with postmenopausal osteoporosis.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 10 Aug 2011 New trial record